The board of directors of CanSino Biologics Inc. announced that Mr. Qiang XU ("Mr. Xu") has tendered his resignation as a non-executive Director, with effect from the date of this announcement, due to his personal work arrangements. The Board also announced the appointment of Mr. Cui, the head of securities affairs department of the Group, as the Board Secretary with effect from the date of this announcement. Mr. Cui will be responsible for management of affairs in relation to capital market, investor relations management and assisting the Board in formulating development strategy in capital market and the formulation and implementation of capital operation projects during his term of office.